OBJECTIVE:To observe and compare the rationality among three combined chemotherapy regimens-TC(TAX+CBP),GP(GEM+DDP) and NP (NVB+DDP) from the perspective of pharmacoeconomics.

• 目的:从药物经济学角度,观察比较TC(TAX+CBP)、GP(GEM+DDP)和NP(NVB+DDP)联合化疗方案的合理性。